Swiss Cancer Institute
Clinical trials sponsored by Swiss Cancer Institute, explained in plain language.
-
Old antibiotic could be new weapon against tough breast cancer cells
Disease control Recruiting nowThis study is testing if adding a common antibiotic called doxycycline to standard chemotherapy can improve treatment for early-stage breast cancer. The goal is to see if doxycycline can target stubborn 'cancer stem cells' that are thought to survive chemo and cause the cancer to…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Heating up the fight: trial tests heat therapy to boost sarcoma survival
Disease control Recruiting nowThis trial is testing whether a new combination treatment approach is practical for patients with high-risk soft tissue sarcomas. It combines chemotherapy with targeted heat therapy, followed by radiation and surgery, to try to improve survival. The study will enroll 24 patients …
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Spinal fluid test could spot hidden brain cancer in lymphoma patients
Diagnosis Recruiting nowThis study is testing whether a new liquid biopsy method can better detect when aggressive B-cell lymphoma has spread to the brain and spinal cord. Researchers will compare this new test, which looks for tumor DNA in spinal fluid, against current standard diagnostic methods. The …
Phase: NA • Sponsor: Swiss Cancer Institute • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC